Here's what we'll cover
Here's what we'll cover
If you're taking a GLP-1 medication for weight loss or type 2 diabetes, you've probably heard about nausea, appetite changes, and the importance of protein intake. But there's one side effect that rarely comes up in prescriber conversations or drug information leaflets: a meaningful increase in fertility.
Researchers, including a professor at the University of Cambridge, are now drawing attention to this issue. The concern is straightforward. Women taking drugs like Ozempic (semaglutide) or Mounjaro (tirzepatide) may become significantly more fertile than they were before starting treatment, often without being told this is happening.
Why GLP-1 Drugs Can Increase Fertility
GLP-1 receptor agonists work by mimicking a natural gut hormone that regulates blood sugar, slows digestion, and signals fullness to the brain. But their effects don't stop there.
Weight loss itself is one of the biggest drivers of fertility change. Excess body fat disrupts the balance of reproductive hormones including estrogen, progesterone, and testosterone. When fat tissue decreases, hormone levels can normalize, which can restart or regulate ovulation in women who had irregular or absent cycles.
The PCOS Connection
Polycystic ovary syndrome (PCOS) is one of the most common causes of infertility in women, and it's closely linked to insulin resistance and excess weight. GLP-1 medications directly address both of those factors.
Women with PCOS who start semaglutide or tirzepatide may find that their menstrual cycles become more regular within months. What this means practically: ovulation may be occurring again when it wasn't before. If a woman and her doctor haven't discussed this, she may not realize her contraception strategy needs to be updated.
Hormonal Shifts Beyond Weight Loss
Some early research suggests GLP-1 receptors may exist in reproductive tissues, including the ovaries. This raises the possibility that these drugs influence fertility through hormonal pathways, not just through weight loss alone. The science here is still emerging, but the clinical picture is growing clearer: GLP-1 use correlates with increased rates of unintended pregnancy.
The Problem With Current Prescribing Practices
Here's where the gap becomes a real patient safety issue. Most prescribers focus the GLP-1 conversation on blood sugar management, cardiovascular benefits, and common side effects like nausea. Fertility is rarely part of that discussion.
Women who have struggled to conceive for years, or who assumed they were effectively infertile due to irregular cycles, may not have updated their birth control methods in a long time. Starting a GLP-1 drug can change their reproductive status without any explicit signal that this is happening.
This isn't a theoretical concern. Clinicians are beginning to report cases of unintended pregnancies in women who had no idea their fertility had returned. The phrase being used by some reproductive health experts is "silent fertility restoration."
Why This Matters More With GLP-1 Drugs Specifically
Not all fertility-boosting treatments come with this same risk of confusion. When a woman undergoes IVF or takes ovulation-stimulating medications, she knows conception is the goal. With GLP-1 drugs, the goal is weight loss or metabolic health. The pregnancy risk is an unintended consequence that can catch patients completely off guard.
Making this more complicated: GLP-1 medications are currently classified as not safe for use during pregnancy. Both semaglutide and tirzepatide carry guidance recommending that women discontinue the medication at least two months before attempting to conceive. The drugs have shown developmental concerns in animal studies, and there is not yet sufficient human data to establish safety during pregnancy.
This creates a scenario where a woman becomes pregnant while taking a drug that should not be used during pregnancy, and may not discover the pregnancy until several weeks in.
The Oral Contraceptive Absorption Problem
There's an additional layer to this issue that many women and providers haven't considered. GLP-1 medications slow gastric emptying, meaning food and medications move through the stomach more slowly than usual. This can affect the absorption of oral medications, including birth control pills.
If a woman is relying on a daily oral contraceptive while taking a GLP-1 drug, the pill may not be absorbed as reliably as expected. Add in GLP-1-related nausea and vomiting, which can further reduce absorption, and the effectiveness of oral contraception may be meaningfully reduced.
This doesn't mean oral contraceptives become ineffective entirely, but it does mean that barrier methods or non-oral forms of birth control (such as an IUD, implant, or injectable) may be more reliable options for women on GLP-1 therapy who are not trying to conceive.
What You Should Ask Your Doctor Before Starting
If you're a woman of reproductive age who is starting, switching, or continuing a GLP-1 medication, these questions deserve a direct conversation with your prescriber.
These are not alarmist questions. They are basic reproductive health questions that should be part of every GLP-1 intake conversation for women of childbearing age.
How This Compares Across GLP-1 Medications
Different GLP-1 medications have different potencies and mechanisms. Wegovy (semaglutide at the higher 2.4 mg weekly dose approved for weight loss) tends to produce more significant weight loss than lower-dose formulations. More weight loss means a potentially larger shift in hormonal balance, which could mean a greater fertility effect.
Mounjaro and Zepbound (tirzepatide) target both GLP-1 and GIP receptors, producing even greater average weight loss in clinical trials. This dual mechanism may also mean a more pronounced hormonal impact, though direct comparative fertility data is not yet available.
Regardless of which GLP-1 medication you are taking or considering, the fertility conversation applies. The specific drug matters less than the fact that any significant weight loss and metabolic improvement can shift your reproductive picture.
What Telehealth GLP-1 Providers Should Be Doing Differently
A significant portion of people now access GLP-1 medications through telehealth platforms rather than in-person clinics. This model has expanded access meaningfully, which is a real benefit for many patients. But it also creates gaps in reproductive health counseling.
A 10-minute async telehealth visit that results in a semaglutide prescription may not include any discussion of fertility, contraception adequacy, or what to do if a pregnancy occurs. The best GLP-1 providers will include reproductive health screening questions as part of their intake process, particularly for women of reproductive age.
When evaluating a telehealth provider, look for evidence that they ask about menstrual cycle regularity, current contraception method, and pregnancy plans. If these questions aren't part of the intake, consider raising them yourself or choosing a provider with more comprehensive onboarding.
No waiting list. No insurance needed.
Frequently Asked Questions
Can GLP-1 medications like Ozempic or Wegovy really increase fertility?
Yes, evidence suggests they can. By promoting significant weight loss and improving insulin sensitivity, GLP-1 drugs can restore hormonal balance and regular ovulation in women who previously had irregular cycles. Women with PCOS appear to be especially susceptible to this effect.
Is it safe to take semaglutide or tirzepatide while pregnant?
No. Both semaglutide and tirzepatide are currently not recommended for use during pregnancy. Animal studies have shown developmental concerns, and there is insufficient human safety data. Women are generally advised to stop GLP-1 medications at least two months before attempting to conceive.
Can GLP-1 drugs affect how well my birth control pill works?
Potentially, yes. GLP-1 medications slow gastric emptying, which can alter the absorption of oral medications including contraceptive pills. Nausea and vomiting, which are common side effects, may further reduce absorption. Non-oral contraceptive methods like IUDs or implants are not affected in the same way.
Which women are most at risk of unexpected pregnancy on GLP-1 drugs?
Women with obesity-related hormonal disruption or PCOS are at the highest risk of fertility restoration because their cycles are most likely to normalize with weight loss and improved insulin sensitivity. However, any woman of reproductive age on a GLP-1 drug should reassess her contraception needs.
How quickly can fertility return after starting a GLP-1 medication?
Fertility changes can happen relatively quickly, sometimes within the first few months of significant weight loss or metabolic improvement. There is no fixed timeline, which is why contraception conversations should happen before or at the start of treatment, not after weight loss has already occurred.
What should I do if I get pregnant while taking a GLP-1 medication?
Stop the medication as soon as you know you are pregnant and contact your doctor or obstetrician immediately. Do not restart the medication without medical guidance. Your provider can help you manage the transition and monitor your pregnancy appropriately.
The Bottom Line: A Conversation That Can't Wait
GLP-1 medications offer real, meaningful benefits for people managing obesity, type 2 diabetes, and related metabolic conditions. Those benefits are not in question. But benefit and risk always travel together, and right now, the fertility risk is not being communicated clearly enough to patients.
If you are a woman of reproductive age taking Ozempic, Wegovy, Mounjaro, or any other GLP-1 medication, this is not a reason to stop your medication without talking to your doctor first. It is a reason to have a direct conversation with your provider about your contraception method, your fertility status, and your plans around pregnancy.
The good news is that this is a manageable risk. Unlike many drug side effects, this one comes with clear, actionable steps. Update your contraception method if needed. Know what to do if a pregnancy occurs. Plan your discontinuation timeline if you do want to conceive.
What to Do Right Now
- If you haven't discussed fertility or contraception with your GLP-1 prescriber, schedule that conversation today.
- If you use oral contraceptives, ask your doctor whether a non-oral method would be more reliable given how GLP-1 drugs affect absorption.
- If you are trying to conceive, talk to your doctor about the recommended medication-free window before attempting pregnancy.
- If you are accessing GLP-1 medications through a telehealth provider, make sure reproductive health is part of your ongoing care, not just your initial intake.
This is exactly the kind of nuanced, practical information that gets lost when GLP-1 coverage focuses only on weight loss numbers and injection technique. The medication works. But working well means understanding the full picture.
If you're still exploring your options or looking for a provider who will take your complete health history seriously, start with our provider comparison guide to find telehealth and in-person services that offer thorough, individualized care. If cost is a concern, check our GLP-1 coupons page for current savings on semaglutide and tirzepatide prescriptions. The right medication, from the right provider, with the right information, is where good outcomes start.